Literature DB >> 2688470

Long-term recovery in alcoholics.

C B De Soto1, W E O'Donnell, J L De Soto.   

Abstract

A cross-sectional study of alcoholics who varied widely in duration of abstinence was combined with a four-year follow-up study of the same subjects. Together, the data demonstrated a course of recovery in abstinent alcoholics measured in three ways: severity of symptoms, probability of relapse, and work history. Additionally, the subjects showed high rates of smoking cessation. By every measure, the course of recovery seemed essentially the same in men and women. The recovery process was most rapid in the early years of abstinence but continued for 10 or more years. It was suggested that keys to full recovery in alcoholics are abstinence and time, which are necessary for recovery from a protracted withdrawal syndrome and brain dysfunction, for the repair of social relationships, for vocational rehabilitation, and for abstinence itself to become stable.

Entities:  

Mesh:

Year:  1989        PMID: 2688470     DOI: 10.1111/j.1530-0277.1989.tb00406.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  20 in total

1.  Stress enhancement of craving during sobriety: a risk for relapse.

Authors:  George R Breese; Kathleen Chu; Christopher V Dayas; Douglas Funk; Darin J Knapp; George F Koob; Dzung Anh Lê; Laura E O'Dell; David H Overstreet; Amanda J Roberts; Rajita Sinha; Glenn R Valdez; Friedbert Weiss
Journal:  Alcohol Clin Exp Res       Date:  2005-02       Impact factor: 3.455

2.  Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout.

Authors:  Kathleen Chu; George F Koob; Maury Cole; Eric P Zorrilla; Amanda J Roberts
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

3.  Prolonged chronic ethanol exposure alters neuropeptide Y and corticotropin-releasing factor levels in the brain of adult Wistar rats.

Authors:  José R Criado; Tianmin Liu; Cindy L Ehlers; Aleksander A Mathé
Journal:  Pharmacol Biochem Behav       Date:  2011-04-17       Impact factor: 3.533

4.  Recovery from alcohol problems with and without treatment: prevalence in two population surveys.

Authors:  L C Sobell; J A Cunningham; M B Sobell
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

5.  Impulsive choice and anxiety-like behavior in adult rats exposed to chronic intermittent ethanol during adolescence and adulthood.

Authors:  Jana Mejia-Toiber; Nathalie Boutros; Athina Markou; Svetlana Semenova
Journal:  Behav Brain Res       Date:  2014-02-22       Impact factor: 3.332

6.  Predicting relapse among young adults: psychometric validation of the Advanced WArning of RElapse (AWARE) scale.

Authors:  John F Kelly; Bettina B Hoeppner; Karen A Urbanoski; Valerie Slaymaker
Journal:  Addict Behav       Date:  2011-06-06       Impact factor: 3.913

7.  A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.

Authors:  David H Overstreet; Darin J Knapp; Sheryl S Moy; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2003-04-04       Impact factor: 4.530

8.  An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders.

Authors:  Michael Dennis; Christy K Scott; Rod Funk
Journal:  Eval Program Plann       Date:  2003-08

9.  Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.

Authors:  Zhongqi Zhang; Andrew C Morse; George F Koob; Gery Schulteis
Journal:  Alcohol Clin Exp Res       Date:  2007-09-14       Impact factor: 3.455

10.  Coadministration of intravenous nicotine and oral alcohol in rats.

Authors:  A D Lê; Steven Lo; Stephen Harding; Walter Juzytsch; Peter W Marinelli; Douglas Funk
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.